Open access
Aug 2026
A universal consuming endogenous H2S strategy using bismuth-metal-organic nanocapsule networks for overcoming osteosarcoma cisplatin resistance
This study identifies endogenous H2S as a key driver of cisplatin resistance in osteosarcoma and develops a novel H2S-targeting theranostic platform named bismuth-based metal-organic nanocapsule network (Bi-MONC), offering a universal approach to scavenge intracellular H2S.
Yi-Xuan Lin, Kai Yuan, Yi-Hao Liu et al.
· Bioactive Materials · 0 citations